2025年末,中欧基金投资总监葛兰在管基金总规模缩水至“300亿元”梯队。 1月22日,据最新披露的2025年四季报,葛兰旗下在管基金总规模由去年三季度末的435.44亿元降至去年四季度末的353.89亿元。 在调仓换股上,中欧医疗健康的前十大重仓股并未发生更迭,海思科、泰格医药获增持,百利天恒、信立泰等多只个股遭减仓;中欧医疗创新大幅度增持了凯莱英H股,并重新买回昭衍新药;中欧明睿新起点则...
Source Link2025年末,中欧基金投资总监葛兰在管基金总规模缩水至“300亿元”梯队。 1月22日,据最新披露的2025年四季报,葛兰旗下在管基金总规模由去年三季度末的435.44亿元降至去年四季度末的353.89亿元。 在调仓换股上,中欧医疗健康的前十大重仓股并未发生更迭,海思科、泰格医药获增持,百利天恒、信立泰等多只个股遭减仓;中欧医疗创新大幅度增持了凯莱英H股,并重新买回昭衍新药;中欧明睿新起点则...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.